• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠小肠中各种吸收促进剂的有效性和毒性筛选:吸收促进剂对酚红肠道吸收以及肠膜蛋白和磷脂释放的影响

Effectiveness and toxicity screening of various absorption enhancers in the rat small intestine: effects of absorption enhancers on the intestinal absorption of phenol red and the release of protein and phospholipids from the intestinal membrane.

作者信息

Yamamoto A, Uchiyama T, Nishikawa R, Fujita T, Muranishi S

机构信息

Department of Biopharmaceutics, Kyoto Pharmaceutical University, Japan.

出版信息

J Pharm Pharmacol. 1996 Dec;48(12):1285-9. doi: 10.1111/j.2042-7158.1996.tb03937.x.

DOI:10.1111/j.2042-7158.1996.tb03937.x
PMID:9004192
Abstract

Sodium glycocholate, sodium taurocholate, sodium deoxycholate, EDTA, sodium salicylate, sodium caprate, diethyl maleate, N-lauryl-beta-D-maltopyranoside, linoleic acid polyoxyethylated (60 mol) mixed micelles (all 20 mM) have been ranked in order of their effectiveness as enhancers of the absorption of drugs in the rat small intestine, by use of an in-situ loop model with phenol red as a model drug. Local toxicity in rats was examined by assessing protein and phospholipid release as biological markers. Of the absorption enhancers, sodium deoxycholate, EDTA and N-lauryl-beta-D-maltopyranoside were the most effective; sodium deoxycholate and EDTA, however, caused significant release of protein and phospholipids. N-lauryl-beta-D-maltopyranoside, on the other hand, did not damage the small intestinal membrane. Sodium taurocholate enhanced phenol red absorption from the small intestine and resulted in little or no protein and phospholipids release. Sodium salicylate, diethyl maleate and the mixed micelles had no absorption-promoting effects on phenol red. There was good correlation between the area under the plasma concentration-time curve for phenol red and the amounts of protein and phospholipid released in the presence of absorption enhancers. From these results it might be concluded that N-lauryl-beta-D-maltopyranoside and sodium taurocholate are effective absorption enhancers which have low toxicity levels at a concentration of 20 mM.

摘要

通过使用以酚红为模型药物的原位肠袢模型,对甘氨胆酸钠、牛磺胆酸钠、脱氧胆酸钠、乙二胺四乙酸(EDTA)、水杨酸钠、癸酸钠、马来酸二乙酯、N-月桂酰-β-D-麦芽吡喃糖苷、聚氧乙烯化(60摩尔)亚油酸混合胶束(均为20毫摩尔)在大鼠小肠中作为药物吸收促进剂的有效性进行了排序。通过评估蛋白质和磷脂的释放作为生物学标志物来检测大鼠的局部毒性。在这些吸收促进剂中,脱氧胆酸钠、EDTA和N-月桂酰-β-D-麦芽吡喃糖苷最为有效;然而,脱氧胆酸钠和EDTA会导致蛋白质和磷脂的大量释放。另一方面,N-月桂酰-β-D-麦芽吡喃糖苷不会损伤小肠膜。牛磺胆酸钠可增强小肠对酚红的吸收,且导致蛋白质和磷脂的释放很少或没有释放。水杨酸钠、马来酸二乙酯和混合胶束对酚红没有吸收促进作用。酚红血浆浓度-时间曲线下的面积与吸收促进剂存在时蛋白质和磷脂的释放量之间存在良好的相关性。从这些结果可以得出结论,N-月桂酰-β-D-麦芽吡喃糖苷和牛磺胆酸钠是有效的吸收促进剂,在20毫摩尔的浓度下毒性水平较低。

相似文献

1
Effectiveness and toxicity screening of various absorption enhancers in the rat small intestine: effects of absorption enhancers on the intestinal absorption of phenol red and the release of protein and phospholipids from the intestinal membrane.大鼠小肠中各种吸收促进剂的有效性和毒性筛选:吸收促进剂对酚红肠道吸收以及肠膜蛋白和磷脂释放的影响
J Pharm Pharmacol. 1996 Dec;48(12):1285-9. doi: 10.1111/j.2042-7158.1996.tb03937.x.
2
Effectiveness and toxicity screening of various absorption enhancers in the large intestine: intestinal absorption of phenol red and protein and phospholipid release from the intestinal membrane.各种吸收促进剂在大肠中的有效性和毒性筛选:酚红的肠道吸收以及肠膜中蛋白质和磷脂的释放
Biol Pharm Bull. 1996 Dec;19(12):1618-21. doi: 10.1248/bpb.19.1618.
3
Effects of various absorption enhancers on the intestinal absorption of water soluble drugs by in vitro Ussing chamber method: correlation with an in situ absorption experiment.采用体外Ussing扩散池法研究不同吸收促进剂对水溶性药物肠道吸收的影响:与原位吸收实验的相关性
Biol Pharm Bull. 1997 Jul;20(7):812-4. doi: 10.1248/bpb.20.812.
4
Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside.多种吸收促进剂对胰岛素透过大鼠肠膜通透性的增强作用:它们对肠黏膜的毒性以及月桂基-β-D-麦芽糖苷的吸收促进机制
J Pharm Pharmacol. 1999 Nov;51(11):1241-50. doi: 10.1211/0022357991776976.
5
Excellent absorption enhancing characteristics of NO donors for improving the intestinal absorption of poorly absorbable compound compared with conventional absorption enhancers.与传统吸收促进剂相比,一氧化氮供体具有出色的吸收增强特性,可改善难吸收化合物的肠道吸收。
Drug Metab Pharmacokinet. 2006 Jun;21(3):222-9. doi: 10.2133/dmpk.21.222.
6
Transport of drugs across the Xenopus pulmonary membrane and their absorption enhancement by various absorption enhancers.药物在非洲爪蟾肺膜上的转运及其被各种吸收促进剂的吸收增强作用。
Pharm Res. 1996 Aug;13(8):1247-51. doi: 10.1023/a:1016080723968.
7
Differences in the promotion mechanism of the colonic absorption of antipyrine, phenol red and cefmetazole.安替比林、酚红和头孢美唑结肠吸收促进机制的差异。
J Pharm Pharmacol. 1987 Feb;39(2):118-23. doi: 10.1111/j.2042-7158.1987.tb06956.x.
8
Improvement of absorption enhancing effects of n-dodecyl-beta-D-maltopyranoside by its colon-specific delivery using chitosan capsules.通过壳聚糖胶囊实现正十二烷基-β-D-麦芽糖苷的结肠特异性递送以提高其吸收增强效果。
Int J Pharm. 2005 Apr 11;293(1-2):127-35. doi: 10.1016/j.ijpharm.2004.12.017.
9
Experimental studies on the influence of surfactants on intestinal absorption of drugs. Cefadroxil as model drug and sodium taurocholate as natural model surfactant: studies in rat colon and in rat duodenum.表面活性剂对药物肠道吸收影响的实验研究。以头孢羟氨苄为模型药物,牛磺胆酸钠为天然模型表面活性剂:大鼠结肠和十二指肠的研究。
Arzneimittelforschung. 1999 Jan;49(1):44-50. doi: 10.1055/s-0031-1300357.
10
Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility.肠道通透性增强:疗效、急性局部毒性及可逆性。
Pharm Res. 1994 Aug;11(8):1132-42. doi: 10.1023/a:1018984731584.

引用本文的文献

1
Mechanistic Studies on the Absorption-Enhancing Effects of Gemini Surfactant on the Intestinal Absorption of Poorly Absorbed Hydrophilic Drugs in Rats.Gemini表面活性剂对大鼠肠道吸收不良的亲水性药物吸收增强作用的机制研究
Pharmaceutics. 2019 Apr 7;11(4):170. doi: 10.3390/pharmaceutics11040170.
2
Effect of chito-oligosaccharide on the oral absorptions of phenolic acids of Flos Lonicerae extract.壳寡糖对金银花提取物中酚酸类成分口服吸收的影响。
Phytomedicine. 2014 Jan 15;21(2):184-94. doi: 10.1016/j.phymed.2013.08.001. Epub 2013 Sep 12.
3
Claudins overexpression in ovarian cancer: potential targets for Clostridium Perfringens Enterotoxin (CPE) based diagnosis and therapy.
紧密连接蛋白在卵巢癌中的过表达:基于产气荚膜梭菌肠毒素(CPE)的诊断和治疗的潜在靶点。
Int J Mol Sci. 2013 May 17;14(5):10412-37. doi: 10.3390/ijms140510412.
4
Improvement of intestinal absorption of forsythoside A and chlorogenic acid by different carboxymethyl chitosan and chito-oligosaccharide, application to Flos Lonicerae-Fructus Forsythiae herb couple preparations.不同羧甲基壳聚糖和壳寡糖对连翘-山茱萸药对中连翘苷和绿原酸肠吸收的改善作用及其应用。
PLoS One. 2013 May 13;8(5):e63348. doi: 10.1371/journal.pone.0063348. Print 2013.
5
On the interaction of Clostridium perfringens enterotoxin with claudins.关于产气荚膜梭菌肠毒素与紧密连接蛋白相互作用的研究。
Toxins (Basel). 2010 Jun;2(6):1336-56. doi: 10.3390/toxins2061336. Epub 2010 Jun 8.
6
Improvement of effect of water-in-oil microemulsion as an oral delivery system for fexofenadine: in vitro and in vivo studies.改善水包油型微乳作为非索非那定口服传递系统的效果:体外和体内研究。
Int J Nanomedicine. 2011;6:1631-40. doi: 10.2147/IJN.S22673. Epub 2011 Aug 12.
7
Omeprazole induces gastric transmucosal permeability to the peptide bradykinin.奥美拉唑诱导胃黏膜对肽类缓激肽的跨黏膜通透性。
World J Gastroenterol. 2010 Mar 7;16(9):1097-103. doi: 10.3748/wjg.v16.i9.1097.
8
Molecular determinants of the interaction between Clostridium perfringens enterotoxin fragments and claudin-3.产气荚膜梭菌肠毒素片段与紧密连接蛋白-3相互作用的分子决定因素
J Biol Chem. 2009 Jul 10;284(28):18863-72. doi: 10.1074/jbc.M109.008623. Epub 2009 May 8.
9
Evaluation of mucosal damage and recovery in the gastrointestinal tract of rats by a penetration enhancer.用渗透促进剂评估大鼠胃肠道的黏膜损伤及恢复情况。
Pharm Res. 2008 Jan;25(1):25-38. doi: 10.1007/s11095-007-9509-8. Epub 2007 Dec 27.
10
Evaluation of the Oral Bioavailability of Low Molecular Weight Heparin Formulated With Glycyrrhetinic Acid as Permeation Enhancer.以甘草次酸作为渗透促进剂配制的低分子量肝素的口服生物利用度评价
Drug Dev Res. 2006 Feb;67(2):166-174. doi: 10.1002/ddr.20087.